Replies to post #32202 on Ariad Pharmaceuticals Inc fka ARIA

[iandy]

I re-read the patent description and claims. I'm wondering if it just adds the PD indication based on their previous preclinical work and others research.
I'm simply not qualified to read the tea leaves if there are any.

[Whosetosay]

Thinking out loud, there has to be 600 patients on the drug by now, or there abouts, and some of them may have a neuro disease on which Ponatinib may have a positive effect.

Might we hear about that? If we see scans of tumors disappearing in a patient, a startling effect on the improvement of a neuro condition, above whatever effect a concurrent medication might provide, could be just as telling, no?